6 results
lupus druginduced arteritis differential dil erythematosus giantcell polychondritis relapsing signs summary symptoms systemic table temporal vasculitides vasculitis
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
) - Diagnosis and ... Manifestations: Malar rash ... Positive in 60-80% of cases ... life-threatening • Treatment ... #rheumatology
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
NPSLE rare, Malar rash ... Manifestations: Malar rash ... #comparison #table ... #rheumatology # ... diagnosis #management
Giant cell arteritis (GCA) Giant cell arteritis (GCA) definition: Most common systemic inflammatory vasculitis in older adults
in literature (NEJM ... (Cornelia NEJM ... Treatment of GCA ... them, but urgent rheumatology ... #Management
Vasculitis and Vasculitides - Differential Diagnosis Framework When to Consider Vasculitis: • Purpura, ischemic skin lesions •
tract, and often causes ... mucositis - Rash ... and branches • GCA ... #rheumatology # ... classification
Drug Induced Lupus (DIL) • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
NPSLE rare, Malar rash ... Discontinuation of causal ... DrugInduced #Lupus #DIL #rheumatology ... #diagnosis #treatment ... #management
Relapsing Polychondritis What is it? Recurrent inflammation of the cartilage in the body (Autoimmune disorder) Who? • Most frequently: 40
such as: • SLE ... Polyarteritis Nodosa, GCA ... affected tissue Treatment ... Polychondritis #rheumatology ... #diagnosis #management
No results found for "rash nejm peds causes management treatment rheumatology gca sle diagnosis classification comparison"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #rash #nejm #peds #causes #management #treatment #rheumatology #gca #sle #diagnosis #classification #comparison